Eureka Therapeutics Announces New England Journal of Medicine Publication of Clinical Study Demonstrating GPRC5D as an Active Target for the Treatment of Multiple Myeloma

EMERYVILLE, Calif.–(BUSINESS WIRE)–Eureka Therapeutics, Inc., a clinical-stage biotechnology company developing novel T cell therapies to treat cancer, today announced the publication of a study in the New England Journal of Medicine entitled “GPRC5D-Targeted CAR T Cells for Myeloma.” The study was led by Dr. Eric Smith of the Dana-Farber Cancer Institute, Dr. Renier Brentjens of … [Read more…]

Carestream’s Recapitalization Plan Confirmed By Court

Expects to Emerge from Recapitalization Process in Coming Days with Strengthened Balance Sheet and Enhanced Financial Flexibility ROCHESTER, N.Y.–(BUSINESS WIRE)–Carestream Health (“Carestream” or the “Company”) today announced that the United States Bankruptcy Court for the District of Delaware (the “Court”) has confirmed the Company’s “prepackaged” restructuring plan. The Company expects to successfully complete its recapitalization … [Read more…]

HIV Clinics Call Out Drug Companies’ Lies

WASHINGTON–(BUSINESS WIRE)–AIDS Healthcare Foundation (AHF) welcomes the release of reports exposing the drug industry’s disinformation campaign attacking the 340B Drug Pricing Program. Ryan White Clinics for 340B Access last week published a rebuttal against the plethora of so-called ‘studies’ whose authors have financial ties to the drug industry. Ryan White Clinics for 340B Access (https://rwc340b.org/), … [Read more…]

Mainstay Medical Announces Publication of Three-Year Patient Outcomes Data from ReActiv8-B Clinical Trial Demonstrating Long-Term Efficacy of ReActiv8® Restorative Neurostimulation™

Data continue to show compelling efficacy and safety, including improvement on all key measures of pain and disability, as compared to the one-year and two-year study results DUBLIN–(BUSINESS WIRE)–Mainstay Medical Holdings plc today announced the publication of the three-year patient outcomes data from its pivotal ReActiv8-B clinical trial. The data, published in the journal of … [Read more…]

Align Technology’s Next Generation Invisalign Virtual Care AI-assisted Remote Monitoring Solution Automates and Streamlines Practice Workflows

Automation – AI-assisted Automatic Assessment and Automated Notifications enable doctors to prioritize treatment tracking exceptions to address treatment progress including patient compliance, key for teens and their parents Integration – Creates a seamless and intelligent, single-platform experience for doctors and their staff through integration with the Invisalign Doctor Site TEMPE, Ariz.–(BUSINESS WIRE)–Align Technology, Inc. (“Align”) … [Read more…]

Sabra Publishes Second Annual Sustainability Report

IRVINE, Calif.–(BUSINESS WIRE)–#ESG–Sabra Health Care REIT, Inc. (“Sabra,” or “we”) (Nasdaq: SBRA) today released its second annual Sustainability Report. The report highlights Sabra’s priorities and initiatives on environmental stewardship, social commitment, corporate governance and community service. “We endeavor to operate efficiently, sustainably and in the best interest of our stakeholders,” said Rick Matros, Sabra’s Chair, … [Read more…]

Calidi Biotherapeutics Appoints David Sans, FAARM, Ph.D., MBA, as Head of Corporate Development

Dr. Sans brings over two decades of life sciences experience spanning investment banking, corporate development, and clinical research LA JOLLA, Calif.–(BUSINESS WIRE)–Calidi Biotherapeutics, Inc. (Calidi), a clinical-stage biotechnology company that is pioneering allogeneic cell-based platforms to revolutionize oncolytic virus therapies, today announced the appointment of David Sans, FAARM, Ph.D, MBA, in New York as Head … [Read more…]

Gov. Newsom Signs Landmark Cancer Access Legislation into Law, California Cancer Coalition Celebrates

Expanded access to optimal cancer care for Medi-Cal beneficiaries outlined in the California Cancer Care Equity Act scheduled to take effect Jan. 1, 2023 SACRAMENTO, Calif.–(BUSINESS WIRE)–The Cancer Care Is Different (CCID) Coalition today commends Gov. Gavin Newsom for signing the California Cancer Care Equity Act (SB 987), a bill that will expand access to … [Read more…]

Cyclo Therapeutics Provides Business Update

– Company on track to commence enrollment and dosing of Phase 2 study of Trappsol® Cyclo™ for the treatment of Alzheimer’s disease before year end – Ongoing advancement of global pivotal study (TransportNPC™) evaluating Trappsol® Cyclo™ for Niemann-Pick Disease Type C1 (NPC1) – Company to participate at the 2022 NPUK Annual Family Conference & Interactive … [Read more…]

Global Biostorage Service Market Analysis & Forecasts, 2017-2021 & 2022-2029: Market Trends and Potential Opportunities in the COVID-19 Landscape – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Biostorage Service Market, Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering. This report focuses on Biostorage Service market revenue at the global, regional, and company level. From a global perspective, this report represents overall Biostorage Service market size by analyzing historical data and future prospect. Key Points Covered in the … [Read more…]